Gel 40

  • Gel 40
  • Gel 40
  • Gel 40
  • Gel 40
Case Reports
Case Reports
Videos
  • Tissue origin :
    Cortico-cancellous heterologous bone mix
  • Tissue collagen :
    Preserved plus an additional 40% collagen gel
  • Composition :
    60% granulated mix, 40% collagen gel
  • Granulometry :
    Up to 300 µm
  • Re-entry time :
    About 4 months
  • Packaging :
    Syringe: 0.5 cc, 3x0.5 cc
  • GMDN code : 46425
Characteristics
Gel 40 is made of a collagen matrix (type I and III) obtained using exclusive Tecnoss® process, loaded for 60% of its volume with micronized heterologous bone (granulometry up to 300 µm). The product is in a gel state at temperatures below 30° C; at higher temperatures the viscosity is reduced and Gel 40 can be mixed with hydrosoluble and/or liposoluble drugs. Thanks to its collagen component, Gel 40 facilitates the formation of primary blood clot and the subsequent invasion of repairing and regenerative cells; moreover the cortico-cancellous component provides the necessary scaffold function. The collagen gel component contained in Gel 40 is rapidly and totally resorbed; it is also endowed with exceptional anti-inflammatory, eutrophic and cicatrizing properties. This lipophilia is due mainly to a percentage of polyunsaturated fatty acids of the oleic-linoleic series (to which Omega 3 also belongs) directly derived from the raw material. Such components possess a valuable antioxidant action on the free radicals and therefore aid tissue regeneration.
Clinical indications
The exclusive Tecnoss® manufacturing process guarantees an exceptional malleability and plasticity: furthermore the syringe packaging provides Gel 40 extraordinary handling properties making this product the ideal choice for crestal access sinus lift1,2, deep and narrow peri-implant defects3, three-wall intrabony defects and, in combination with Evolution membranes, for gingival recessions4. Thanks to the collagen component, Gel 40 facilitates blood clotting and the subsequent invasion of repairing and regenerative cells.
Furthermore, the Tecnoss® manufacturing process avoids granules ceramization, allowing a progressive resorption of the biomaterial and, at the same time, a significant new-bone formation rate5. Gel 40 "soft" consistency also guarantees an easy and healthy soft-tissues healing.
Bibliography
1 BARONE A, CORNELINI R, CIAGLIA R, COVANI U
IMPLANT PLACEMENT IN FRESH EXTRACTION SOCKETS AND SIMULTANEOUS OSTEOTOME SINUS FLOOR ELEVATION: A CASE SERIES
INT J PERIODONTICS RESTORATIVE DENT, 2008 JUN; 28(3):283-9

2 SANTAGATA M, GUARINIELLO L, RAUSO R, TARTARO G
IMMEDIATE LOADING OF DENTAL IMPLANT AFTER SINUS FLOOR ELEVATION WITH OSTEOTOME TECHNIQUE: A CLINICAL REPORT AND PRELIMINARY RADIOGRAPHIC RESULTS
J ORAL IMPLANTOL, 2010 DEC; 36(6):485-489

3 COVANI U, CORNELINI R, BARONE A
BUCCAL BONE AUGMENTATION AROUND IMMEDIATE IMPLANTS WITH AND WITHOUT FLAP ELEVATION: A MODIFIED APPROACH
INT J ORAL MAXILLOFAC IMPLANTS, 2008 SEP-OCT; 23(5):841-6

1 CARDAROPOLI D, CARDAROPOLI G
HEALING OF GINGIVAL RECESSIONS USING A COLLAGEN MEMBRANE WITH A DEMINERALIZED XENOGRAFT: A RANDOMIZED CONTROLLED CLINICAL TRIAL
INT J PERIODONTICS RESTORATIVE DENT, 2009 FEB;29(1):59-67

5 NANNMARK U, AZARMEHR I
SHORT COMMUNICATION: COLLAGENATED CORTICOCANCELLOUS PORCINE BONE GRAFTS. A STUDY IN RABBIT MAXILLARY DEFECTS
CLIN IMPLANT DENT RELAT RES, 2010 JUN 1; 12(2):161-3
© 2019 Copyright by Tecnoss Dental Srl. P.I. 08917490016 REA: TO – 1010057. All rights reserved. Web Site developed by DSI Design
Disclosure on personal data processing - Information for customers - Information for suppliers